Showing 41 - 60 results of 107 for search '"theranostic"', query time: 0.06s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46

    Prostate-Specific Membrane Antigen as Target for Neuroimaging of Central Nervous System Tumors by Brittany M. Stopa, James Crowley, Csaba Juhász, Cara M. Rogers, Mark R. Witcher, Jackson W. Kiser

    Published 2022-01-01
    “…Following the encouraging findings of several such case reports, there is a growing interest in the potential application of PSMA-targeted PET imaging for diagnostics, theranostics, and monitoring of CNS tumors. This is a systematic literature review on PSMA-binding tracers in CNS tumors. …”
    Get full text
    Article
  7. 47
  8. 48
  9. 49

    Synthetic Approaches Toward Phosphorus-Containing BODIPY and Squaraine Dyes: Enhancing Versatility of Small-Molecule Fluorophores by Jeanne M. Favret, Sergei V. Dzyuba

    Published 2024-12-01
    “…These modifications often influence key spectroscopic properties and molecular functionality by expanding their utility in bioimaging, sensing, photosensitization, and theranostic applications. By leveraging the tunable nature of phosphorus-containing moieties, these dyes hold immense promise for addressing current challenges in spectroscopy, imaging, and material designs while unlocking new opportunities for advanced functional systems in chemistry, biology, and medicine.…”
    Get full text
    Article
  10. 50

    Release of biologically relevant substrates from prodrugs and nanocarriers using X- and γ-rays as trigger signals by Kumar, Amit, Dalko, Peter István

    Published 2024-07-01
    “…X- and γ-ray-excited theranostic techniques are increasingly being developed for biomedical applications, as they overcome the limitations of light penetration and tissue attenuation. …”
    Get full text
    Article
  11. 51

    Nano–bio surface interactions, cellular internalisation in cancer cells and e‐data portals of nanomaterials: A review by Ram Dhan Yadav, Abha Chaudhary

    Published 2021-08-01
    “…Abstract Nanomaterials (NMs) have abundant applications in areas such as electronics, energy, environment industries, biosensors, nano devices, theranostic platforms, etc. Nanoparticles can increase the solubility and stability of drug‐loaded materials, enhance their internalisation, protect them from initial destruction in the biological system, and lengthen their circulation time. …”
    Get full text
    Article
  12. 52

    A self-assembling nanoplatform for pyroptosis and ferroptosis enhanced cancer photoimmunotherapy by Zhichao Wang, Yuqi Tang, Quan Li

    Published 2025-01-01
    “…Herein, a multifunctional pH-responsive theranostic nanoplatform (M@P) is designed and constructed by self-assembly of aggregation-induced emission photosensitizer MTCN-3 and immunoadjuvant Poly(I: C), which are further encapsulated in amphiphilic polymers. …”
    Get full text
    Article
  13. 53
  14. 54

    Curing Temperature Effects on the Tensile Properties and Hardness of γ−Fe2O3 Reinforced PDMS Nanocomposites by Yvonne Konku-Asase, Abu Yaya, Kwabena Kan-Dapaah

    Published 2020-01-01
    “…The mechanical properties of plain polydimethylsiloxane (PDMS) and its nanocomposites have been exploited for various theranostic biomedical applications. Although several research groups have investigated the effects of preparation conditions—especially curing temperature and time—on bulk mechanical properties of plain PDMS, there are no reported similar studies for its nanocomposites. …”
    Get full text
    Article
  15. 55

    FITA-Containing 2,4-Dinitrophenyl Alkylthioether-Based Probe for Detection and Imaging of GSH by Yalun Dong, Liyue Wang, Wenfang Liang, Jiqin Zhu, Lu Sun, Long Yi

    Published 2024-12-01
    “…Probes for detection and imaging of GSH are not only useful for understanding GSH chemical biology but are also important for exploring potential theranostic agents. Herein, we report a fast intramolecular thiol-activated arylselenoamides (<b>FITA</b>)-based fluorescent probe using 2,4-dinitrophenyl alkylthioether as a sulfydryl-selective receptor for the first time. …”
    Get full text
    Article
  16. 56

    Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine by Izadiyan Z, Misran M, Kalantari K, Webster TJ, Kia P, Basrowi NA, Rasouli E, Shameli K

    Published 2025-01-01
    “…The integration of immunotherapeutic agents within liposomes marks a paradigm shift, enabling the design of ‘immuno-modulatory hubs’ capable of orchestrating precise immune responses while facilitating theranostic applications. The recent COVID-19 pandemic has accelerated research in liposomal-based vaccines and antiviral therapies, underscoring the need for improved delivery mechanisms to overcome challenges like rapid clearance and organ toxicity. …”
    Get full text
    Article
  17. 57

    Recent Advances in Indocyanine Green-Based Probes for Second Near-Infrared Fluorescence Imaging and Therapy by Dehong Hu, Menglei Zha, Hairong Zheng, Duyang Gao, Zonghai Sheng

    Published 2025-01-01
    “…Recent advancements in NIR-II imaging technology have revitalized interest in ICG, revealing its extended tail fluorescence beyond 1,000 nm and reaffirming its potential as a clinically translatable NIR-II fluorophore for in vivo imaging and theranostic applications for diagnosing various diseases. …”
    Get full text
    Article
  18. 58

    Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer? by Tryambak Pratap Srivastava, Ruby Dhar, Subhradip Karmakar

    Published 2025-01-01
    “…The systemic management of breast cancer is guided primarily by theranostic biomarkers; ER, PR, HER2, and Ki67 which also dictate the breast cancer classification. …”
    Get full text
    Article
  19. 59

    Rare Cell Population Analysis in Early-Stage Breast Cancer Patients by Stefan Schreier, Prapaphan Budchart, Suparerk Borwornpinyo, Lakkana Adireklarpwong, Prakasit Chirappapha, Wannapong Triampo, Panuwat Lertsithichai

    Published 2025-01-01
    “…Background: Circulating rare cells participate in breast cancer evolution as systemic components of the disease and thus, are a source of theranostic information. Exploration of cancer-associated rare cells is in its infancy. …”
    Get full text
    Article
  20. 60

    Direct imaging with multidimensional labelling and high‐content analysis allows quantitative categorization and characterizations of individual small extracellular vesicles and nan... by Simou Sun, Sarah J. Cox‐Vázquez, Nam‐Joon Cho, Guillermo C. Bazan, Jay T. Groves

    Published 2024-12-01
    “…This platform is poised to advance sEVP‐based theranostic assays and facilitate exploration into disease‐associated sEVP biogenesis and sEVP‐mediated intercellular communication.…”
    Get full text
    Article